A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Neha Korde, Mattias Carlsten, Min Jung Lee, Alex Minter, Esther Tan, Mary Kwok, Elisabet Manasanch, Manisha Bhutani, Nishant Tageja, Mark Roschewski, Adriana Zingone, Rene Costello, Marcia Mulquin, Diamond Zuchlinski, Irina Maric, Katherine R. Calvo, Raul Braylan, Prashant Tembhare, Constance Yuan, Maryalice Stetler-StevensonJane Trepel, Richard Childs, Ola Landgren

Research output: Contribution to journalLetterpeer-review

83 Scopus citations
Original languageEnglish (US)
Pages (from-to)e81-e83
JournalHaematologica
Volume99
Issue number6
DOIs
StatePublished - Jun 1 2014
Externally publishedYes

Keywords

  • Clinical response
  • HLA-C binding KIR2D reports
  • IPH2101
  • KIR2D blockade
  • NK-cell function
  • Smoldering multiple myeloma

ASJC Scopus subject areas

  • Hematology

Cite this